High expression of LAG3 on tumor infiltrating lymphocytes and the presence of its soluble form (sLAG3) in the serum of patients has been associated with a better prognosis in some types of cancer, including hormone receptor positive breast cancer [22,28], gastric cancer [27], and colon cancer [26]. Here, LAG3 is linked to malignant colon neoplasm.